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012.08.0Abstract Aim: To determine the outcomes of percutaneous coronary intervention (PCI) in
patients presenting with ST-segment elevation myocardial infarction (STEMI) according to PCI
guidelines.
Methods: This study was conducted between January 2008 and December 2010. A total of 450
patients presenting with STEMI underwent PCI: 288 patients underwent primary PCI, and 162
patients underwent non-primary PCI.
Results: The mean age at presentation was 55 ± 11.10 years and 89.8% were male. The door-to-
balloon time was 60 min in primary PCI group (288 patients). The median time between end of
failed thrombolytic therapy and the rescue PCI was 420 min (95 patients) versus 810 min after suc-
cessful thrombolytic therapy (35 patients). Only 32 patients underwent late PCIP 24 h and 648 h
without thrombolytic therapy; median time was 2160 min. In-hospital, 30 days and 6-months mor-
tality were respectively 2.1%, 0.7% and 1.1% in primary PCI group while 2.5%, 3.2% and 2.6% in
non-primary PCI group. In-hospital, 30 days and 6-months reinfarction occurred in 0.3%, 1.1%
and 0.7% of patients in primary PCI group while 0.0%, 1.3% and 0.7% in non-primary PCI group
respectively. In-hospital, 30 days and 6-months TVR occurred in 0.7%, 0.7% and 1.1% of patients
in primary PCI group while 0.0%, 1.3% and 0.7% in non-primary PCI group respectively.
Conclusions: This is the ﬁrst report from Egyptian hospital to provide a comprehensive review of
patient characteristics and outcomes of PCI for STEMI. We reported a high initial success rate,
excellent short and intermediate-term outcomes.
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041. Introduction
Myocardial infarction is a medical emergency which demands
both immediate attention and activation of the emergency
medical services because it is the leading cause of death for
both men and women all over the world.1 Of all patients hav-
ing a myocardial infarction, 25–35% will die before receiving
medical attention.2 The ultimate goal of the management ing by Elsevier B.V. All rights reserved.
164 M. Sadaka et al.the acute phase of the disease is, to salvage as much myocar-
dium as possible and prevent further complications, either with
thrombolytic therapy or primary PCI. As time passes, the risk
of damage to the heart muscle increases; hence the phrase that
in myocardial infarction, ‘‘time is muscle’’ and ‘‘time wasted is
muscle lost’’.3
Thrombolytic therapy to abort a myocardial infarction is
not always effective. The degree of effectiveness of a throm-
bolytic agent is dependent on the time since the myocardial
infarction began, with the best results occurring if the
thrombolytic agent is used within 2 h of the onset of symp-
toms.4 Failure rates of thrombolytic can be as high as 20%
or higher.5
Reperfusion of the infarct artery can also be achieved by a
catheter-based strategy. When PCI is used in lieu of ﬁbrinolytic
therapy within 12 h of onset of STEMI, it is referred to as pri-
mary PCI. When ﬁbrinolytic has failed to reperfuse the infarct
vessel or a severe stenosis is present in the infarct vessel, a res-
cue PCI can be performed, 12 h after failed ﬁbrinolytic, to sal-
vage as much myocardium as possible and prevent further
complications. An approach of ischemia-driven PCI can be
used to manage STEMI patients only when spontaneous or
exercise-provoked ischemia occurs, whether or not they have
received a previous course of ﬁbrinolytic therapy. Post-throm-
bolytic PCI is reasonable in patients with STEMI and a patent
infarct artery 3–24 h after ﬁbrinolytic therapy.6
Patients with STEMI presenting to a hospital without PCI
capability should be transferred for 1ry PCI within 120 min of
ﬁrst medical contact and if not possible and ﬁbrinolytic ther-
apy was given as primary reperfusion therapy, patients should
be transferred to a PCI-capable facility as soon as possible
where PCI can be performed when needed.7
Data collected from ACESS registry concluded that, in
Egypt, acute coronary syndromes (ACS) occur at a younger
age, treatment of ACS follows the international practice
guidelines but mainly conservative and reperfusion therapies
are not implemented in about 60% of cases. These ﬁndings
suggest opportunities to reduce further the risk of long-term
ischemic events in ACS patients in developing countries
including Egypt which is currently contributing to the Euro-
pean project of stent for life (SFL) as a one of 10 target
countries in the next few years with many pilot centers
including our center.8Table 1 Distribution of the studied cases according to type of
PCI.
Type of PCI Total no. = 450
No %
Primary (0–12 h) 288 64.0
Non-primary 162 36.0
Rescue (0–12 h) 95 21.1
Post successful thrombolytic (0–24 h) 35 7.8
Late PCI (24–48 h)
Ischemia-driven 23 5.1
Late PCI in cardiogenic shock 9 2.02. Methods
A single-center, retrospective study was conducted at a tertiary
care Hospital {International Cardiac Centre (ICC), Alexan-
dria, Egypt} during the period January 1st, 2008 to December
31st, 2010. A total of 450 consecutive patients presenting with
STEMI were transferred from 19 community hospitals and
underwent PCI: 288 patients presented within 12 h of the onset
of symptoms underwent primary PCI and 162 patients trans-
ferred from 19 community hospitals and underwent non-pri-
mary PCI (95 patients underwent rescue PCI within 12 h
after failed thrombolytic therapy, 35 patients underwent coro-
nary angiography and PCI within 24 h after successful throm-
bolytic therapy while 32 patients underwent late PCI after 24 h
and less than 48 h without thrombolytic therapy driven by per-
sistent chest pain, dynamic ECG changes, preserved systolic
function or cardiogenic shock).All patients were subjected to detailed history taking, clin-
ical evaluation, ECG analysis, echocardiography and labora-
tory investigations.
Chest pain-to-ER, door-to-balloon, time from the end of
failed thrombolytic therapy to the rescue PCI, time from end
of successful thrombolytic therapy to PCI and the time from
chest pain to late PCI were computed and given in minutes.
Coronary angiography and PCI procedure were described
including materials used and the intra-procedure complica-
tions were also documented. Patients were put under observa-
tion to detect the occurrence of any in-hospital MACE or
other hemodynamic complications.
The primary outcomes were a composite of death, reinfarc-
tion, stroke, or target vessel revascularization (TVR) in-hospi-
tal, 30 days and at 6 months.
All the patients were contacted for follow up at 30 days and
6 months after the procedure by interviewing with the patients
via telephone or the responsible physician to determine the
clinical outcomes of the procedure.
2.1. Statistical analysis
Data were analyzed using SPSS software package version 18.0
(SPSS, Chicago, IL, USA). Quantitative data were expressed
using Range, mean, standard deviation and median while
Qualitative data were expressed in frequency and percent.
Qualitative data were analyzed using Chi-square test also exact
tests such Fisher exact and Monte Carlo was applied to com-
pare different groups, while McNemar–Bowker was used to
analyze the signiﬁcance between the different stages. Not nor-
mally distributed quantitative data were analyzed using Mann
Whitney test for comparing two groups. P value was assumed
to be signiﬁcant at 0.05.
3. Results
Our population consisted of 450 consecutive STEMI patients
studied retrospectively: 288 patients presented within 12 h of
the onset of symptoms underwent primary PCI, and 162 pa-
tients transferred from 19 community hospitals and underwent
non-primary PCI (95 patients underwent rescue PCI within
12 h after failed thrombolytic therapy, 35 patients underwent
coronary angiography and PCI within 24 h after successful
thrombolytic therapy while 32 patients underwent late PCI
after 24 h and less than 48 h without thrombolytic therapy dri-
ven by persistent chest pain, dynamic ECG changes, preserved
systolic function or cardiogenic shock) as seen in (Table 1).
Table 2 Comparison between the two studied groups according to demographic and admission data.
Variables Type of PCI
Non-1ry (n= 162) 1ry (n= 288)
Rescue Post successful thrombolytic Late PCI Total (n= 162)
Ischemia-driven In cardiogenic shock
No. % No. % No. % No. % No. % No. %
Age
Range 26.0–80.0 28.0–74.0 36.0–81.0 48.0–80.0 26.0–81.0 22.0–85.0
Mean ± SD 54.95 ± 11.57 43.91 ± 12.11 59.35 ± 10.61 62.33 ± 10.34 55.70 ± 10.53 55.89 ± 11.11
Median 57.0 51.0 67.0 50.0 55.0 55.0
Sex
Male 84 51.9 31 19.1 21 13.0 8 4.9 144 88.9 260 90.3
Female 11 6.8 4 2.5 2 1.2 1 0.6 18 11.1 28 9.7
DM
IDDM 8 4.9 1 0.6 1 0.6 1 0.6 11 6.8 7 2.4
NIDDM 48 29.6 22 13.6 12 7.4 7 4.3 89 54.9 118 41.0
Total 56 34.6 23 14.2 13 8.0 8 4.9 100 61.7 125 43.4
Hypertension 35 21.6 14 8.6 11 6.8 3 1.9 63 38.9 108 37.5
Hyperlipidemia 47 29.0 19 11.7 7 4.3 2 1.2 75 46.3 161 55.9
Current Smoking 61 37.6 18 11.1 14 8.6 4 2.5 97 59.8 162 56.2
Prior MI 1 0.6 1 0.6 0 0.0 0 0.0 2 1.2 11 3.8
Prior PCI 2 1.2 0 0.0 2 1.2 0 0.0 4 2.5 15 2.5
Prior CABG 0 0.0 0 0.0 2 1.2 0 0.0 2 1.2 3 1.0
Diagnosis
Anterior 61 37.6 18 11.1 13 8.0 8 4.9 100 61.7 173 60.1
Inferior 33 20.4 16 9.9 10 6.2 1 0.6 60 37.0 106 36.8
Lateral 1 0.6 1 0.6 0 0.0 0 0.0 2 1.2 9 3.1
Killip class
I 92 56.8 35 21.6 22 13.6 10 6.2 149 92.0 262 91.0
II 1 0.6 0 0.0 1 0.6 0 0.0 2 1.2 16 5.6
III 2 1.2 0 0.0 0 0.0 0 0.0 2 1.2 1 0.3
IV 0 0.0 0 0.0 0 0.0 9 5.6 9 5.6 9 3.1
Cardiac arrest 2 1.2 1 0.6 0 0.0 2 1.2 5 3.1 8 2.8
Required intubation 2 1.2 0 0.0 0 0.0 2 1.2 4 2.5 4 1.4
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89.8% were male. Cardiovascular risk factors were mainly
smoking (57.6%), dyslipidemia (52.4%), diabetes (50%) and
hypertension (38%). Majority of our patients presented with
Killip class I, (91% in 1ry PCI group and 92% in non-1ry
PCI group), while 3.1% in 1ry PCI group and 5.6% in non-
1ry PCI group presented with Killip class IV (cardiogenic
shock). Eight patients in 1ry PCI group and ﬁve patients in
non-1ry PCI group arrested at admission. Four patients in
each group required intubation and mechanical ventilation
(Table 2).
The median time from onset of symptoms to presentation
was 240 min (4 h) and the median door-to-balloon time was
60 min in primary PCI group (288 patients). The median time
between end of failed thrombolytic therapy and the rescue PCI
was 7 h (95 patients) while the median time between end of
successful thrombolytic therapy and PCI was 13.5 h (35 pa-
tients). Only 32 patients underwent late PCIP 24 h and
648 h without thrombolytic therapy; median time was 36 h
(Table 3).
As regards angiographic data, LAD represented the culprit
vessel in 60.9% of our patients and initial TIMI ﬂow was less
than 2 in 78.5% of patients in 1ry PCI group and 48.8% innon-1ry PCI group. Glycoprotein (GP) IIb/IIIa inhibitor was
used in 97.6% of patients in primary PCI group while not uti-
lized in non-primary PCI group. Thrombus aspiration was
done in 41% of patients in primary PCI group and 12.3% in
non-primary PCI group. During the angioplasty procedure, di-
rect stenting was 41.3% among 1ry PCI patients and 56.2%
among non-primary PCI patients. Bare metal stents (BMS)
were used in 71.3% of whole patients while drug eluting stents
(DES) were used in 28.5% of whole patients. Multivessel PCI
at the same setting was done in 8.2% of the whole patients (Ta-
ble 4 and 5).
TIMI ﬂow II–III grade was obtained in 99.3% of 1ry PCI
patients and 98.8% of non-primary PCI patients and myocar-
dial blush grade (MBG) II–III was obtained in 96.5% of 1ry
PCI patients and 96.9% of non-primary PCI patients. The pro-
cedural success was achieved in 98.9% of the whole patients.
As regard intra-procedural complications; dissection occurred
in 1% of 1ry PCI patients and 1.2% of non-primary PCI pa-
tients, no reﬂow occurred in 4.5% of 1ry PCI patients and
10.5% of non-primary PCI patients; perforation occurred in
0.7% of primary PCI patients; re-occlusion occurred in 1%
of primary PCI patients; cardiac arrest occurred in 2.5% of
primary PCI patients and 2.8% of non-primary PCI patients.
Table 3 Comparison between the studied groups according to timing variables.
Timing variables (min) Type of PCI
Non-1ry (n= 162) 1ry (n= 288)
Rescue Post successful
thrombolytic
Late PCI
Ischemia-driven In cardiogenic shock
Chest pain to ER
Range 60.0–720.0 30.0–180 1440.0–2880.0 30.0–720.0
Mean ± SD 274.35 ± 277.78 85.05 ± 90.13 1451.11 ± 1458.23 321.35 ± 305.55
Median 180.0 120.0 2100.0 240.0
Door-to-balloon
Range – – – – 20.0–180.0
Mean ± SD – – – – 68.91 ± 23.25
Median – – – – 60.0
End of failed thrombolytic therapy
and the rescue PCI
Range 240.0–600.0 – – – –
Mean ± SD 290.15 ± 298.35 – – – –
Median 420.0 – – – –
End of successful thrombolytic therapy
and PCI
Range – 240.0–1440.0 – – –
Mean ± SD – 625.15 ± 633.11 – – –
Median – 810.0 – – –
Chest pain to late PCI
Range – – 1440.0–2880.0 -
Mean ± SD – – 1443.12 ± 1446.17 -
Median – – 2160.0 -
Table 4 Comparison between the studied groups according to baseline characteristics of coronary angiography.
Variables Non-primary PCI (n= 162) Primary PCI (n= 288)
No % No %
Culprit vessel
LAD/D 98 60.5 176 61.1
LCX/OM 14 8.6 29 10.1
RCA 49 30.2 82 28.5
Left main 1 0.6 2 0.7
Graft 1 0.6 1 0.3
No. of diseased vessels
Single 76 46.9 132 45.8
Two 64 39.5 101 35.1
Three 22 13.0 55 19.1
TIMI ﬂow pre-PCI
0 44 27.2 191 66.3
I 35 21.6 35 12.2
II 74 45.7 44 15.3
III 9 5.6 18 6.3
Visible thrombus 33 20.4 153 53.1
166 M. Sadaka et al.Major bleeding occurred in 1.4% of patients in primary PCI
group and 2.4% in non-primary PCI group. 3.1% of patients
developed contrast induced nephropathy (CIN) during the in-
hospital course (Table 6).
In-hospital, 30 days and 6-months all cause mortality were
respectively 2.1%, 0.7% and 1.1% in primary PCI group while
2.5%, 3.2% and 2.6% in non-primary PCI group. All causemortalities were all due to cardiac mortality; either by sudden
deaths or by fatal re-infarctions.
In-hospital, 30 days and 6-months re-infarction occurred in
0.3%, 1.1% and 0.7% of patients in primary PCI group; while
0.0%, 1.3% and 0.7% in non-primary PCI group respectively.
The in-hospital re-infarction in all patients occurred in the cul-
prit vessel due to stent thrombosis documented by coronary
Table 6 Comparison between the two studied groups according to procedure outcome and complication.
Variables Non-primary PCI (n= 162) Primary PCI (n= 288)
No % No %
TIMI ﬂow post-PCI
0 2 1.2 2 0.7
I 0 0.0 0 0.0
II 12 7.4 20 6.9
III 148 91.4 266 92.4
MBG post-PCI
0 2 1.2 3 1.0
I 3 1.9 7 2.4
II 26 16.0 57 19.8
III 131 80.9 221 76.7
Procedure success 160 98.8 285 99.0
Procedure complications
Dissection 2 1.2 3 1.0
Re-occlusion 0 0.0 3 1.0
No reﬂow 17 10.5 13 4.5
Perforation 0 0.0 2 0.7
Cardiac arrest 4 2.5 8 2.8
Table 5 Comparison between the two studied groups according to procedural-related techniques and materials.
Variables Non-primary PCI (n= 162) Primary PCI (n= 288)
No. % No. %
GPIIb IIIa inhibitor 0 0.0 281 97.6
Thrombus aspiration 20 12.3 118 41.0
No. of vessels attempted
One 150 92.6 259 90.0
Two 10 6.2 26 9.0
Three 2 1.2 3 1.0
Multivessel PCI 10 6.2 27 9.4
Direct stenting 91 56.2 119 41.3
Type of stent used
BMS 101 62.3 212 73.6
DES 58 35.8 67 23.3
POBA 1 0.6 7 2.4
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angioplasty; while the mechanism of 30 days and 6-months re-
infarction was not documented by coronary angiography in all
patients, as not all patients were rehospitalized to our center
during follow up period.
In-hospital, 30 days and 6-months TVR occurred in
0.7%, 0.7% and 1.1% of patients in primary PCI group
while 0.0%, 1.3% and 0.7% in non-primary PCI group
respectively.The patients required TVR either due to stent
thrombosis or in-stent restenosis of BMS. TVR was done
in all documented cases either by just POBA (plain ordinary
balloon angioplasty) or implantations of DES inside BMS,
as the majority of our patients had BMS (73.6% in primary
PCI group versus 62.3% in non-primary PCI group). Two
patients had elective coronary artery bypass graft (CABG)
in primary PCI group while none of non-primary PCI group
patients required elective surgery during the 6 months follow-
up period. There was no emergent CABG in both groups
(Tables 7 and 8).3.1. Comparison between thrombus aspiration and conventional
PCI in patients treated with primary PCI
Thrombus aspiration before PCI was done in 41% of our 1ry
PCI patients using Diver ce in 51 patients and Export catheter
in 67 patients.
Angiographic and procedural details of the two study
group are shown in Table 9. At initial angiography, there
was a higher incidence of baseline TIMI 0–1 ﬂow in patients
treated with thrombus aspiration before PCI compared with
those treated with conventional PCI (87.3% versus 72.4%,
p= 0.002). MBG post-PCI is better in the thrombus aspira-
tion group with signiﬁcant difference than that obtained in
the conventional PCI group. No reﬂow occurred less in the
thrombus aspiration group but with no signiﬁcant difference
(2.5% versus 5.9%, p= 0.251). Otherwise procedure charac-
teristics did not differ substantially between the two groups.
A case example of male patient aged 54 years old, hyperten-
sive, heavy smoker and dyslipidemic, presented with anterior
Table 7 Comparison between the two studied groups according to in-hospital course.
Variables Type of PCI
Non-1ry (n= 162) 1ry (n= 288)
Rescue Post successful thrombolytic Late PCI Total (n= 162)
Ischemia-driven In cardiogenic shock
No. % No. % No. % No. % No. % No. %
Death 0 0.0 0 0.0 1 0.6 3 1.9 4 2.5 6 2.1
Re-infarction 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 0.3
Re-intervention
TVR 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 0.7
Non-TVR 3 1.9 2 1.2 0 0.0 0 0.0 5 3.1 10 3.5
Major bleeding 2 1.2 1 0.6 0 0.0 1 0.6 4 2.5 4 1.4
Minor bleeding 3 1.9 1 0.6 1 0.6 1 0.6 6 3.7 8 2.8
CIN 2 1.2 0 0.0 1 0.6 2 1.2 5 3.1 9 3.1
Stroke 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 0.7
Emergency CABG 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Table 8 Comparison between the two studied groups according to 30-days and 6-months follow up.
Variables Type of PCI
Non-1ry 1ry (n= 282)
Rescue Post successful
thrombolytic
Late PCI Total (n= 158)
Ischemia-driven In cardiogenic
shock
No. % No. % No. % No. % No. % No. %
30 Days follow up Death 2 1.3 1 0.6 1 0.6 1 0.6 5 3.2 2 0.7
Re-infarction 0 0.0 0 0.0 1 0.6 1 0.6 2 1.3 3 1.1
Stroke 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Bleeding 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Revascularization
TVR 0 0.0 0 0.0 1 0.6 1 0.6 2 1.3 2 0.7
Non-TVR 12 7.6 6 3.8 6 3.8 2 1.3 26 16.5 2 0.7
Variables Total (n= 153) (n= 280)
6-Months follow up Death 3 1.9 0 0.0 1 0.7 0 0.0 4 2.6 3 1.1
Re-infarction 1 0.7 0 0.0 0 0.0 0 0.0 1 0.7 2 0.7
Stroke 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Bleeding 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0
Revascularization
TVR 1 0.7 0 0.0 0 0.0 0 0.0 1 0.7 3 1.1
Non-TVR 1 0.7 2 1.2 0 0.0 0 0.0 3 1.9 5 1.8
168 M. Sadaka et al.STEMI of 1 h duration. Patient was then transferred to cath.
Lab for 1ry PCI with door-to-balloon time 40 min. Thrombus
aspiration was performed with export catheter followed by di-
rect stenting with Taxus liberte stent 2.5 · 38 mm with excel-
lent ﬁnal result and TIMI III ﬂow (Fig. 1).
4. Discussion
More than 10 years ago, survival beneﬁt of primary PCI for
STEMI was demonstrated in several randomized trials. Since
then, primary PCI has been implemented in routine daily prac-
tice and is in the guidelines of the preferred reperfusion therapy
for patients with STEMI.9
Although widely adopted as the default strategy for pa-
tients presenting with STEMI in developed nations, there are
virtually few data on the applicability, success and outcomesof primary PCI in developing countries with limited follow
up.10
In our country primary PCI is not available for all our
STEMI patients, and so they receive thrombolytic therapy.
We use what is called non-primary PCI for management STE-
MI patients not received primary PCI in which we collect post
thrombolytic PCI {rescue PCI for failed thrombolytic, routine
early PCI within 24 h of thrombolytic and ischemia- driven
PCI}.
4.1. Baseline clinical characteristics
In our study the mean age at presentation was
55 ± 11.10 years and 89.8% were male. Cardiovascular risk
factors were mainly smoking (57.6%), dyslipidemia (52.4%),
diabetes (50%) and hypertension (38%). Majority of our pa-
Table 9 Angiographic and procedural details of TA and conventional PCI groups.
Thrombus aspiration (n= 118) Conventional PCI (n= 170) Test of sig.
No. % No. %
GPIIb/IIIa inhibitor 117 99.2 164 96.5 FEp = 0.246
Baseline TIMI 0–1 103 87.3 123 72.4 v2p = 0.002*
Stented patients 114 96.6 165 97.1 FEp = 1.000
Direct stenting 80 67.8 126 74.1 v2p = 0.242
Final TIMI 3 ﬂow 109 92.4 157 92.4 v2p = 0.995
MBG post-PCI
Grade 0–1 1 0.8 9 5.3 v2p < 0.001*
Grade 2 8 6.8 49 28.8
Grade 3 109 92.4 112 65.9
Procedure complications
Dissection 1 0.8 2 1.2 FEp = 1.000
No reﬂow 3 2.5 10 5.9 FEp = 0.251
Re-occlusion 1 0.8 2 1.2 FEp = 1.000
Perforation 2 1.7 0 0.0 FEp = 0.167
Cardiac arrest 4 3.4 4 2.4 FEp = 0.720
v2p: p value for Chi square test.
FEp: p value for Fisher Exact test.
* Statistically signiﬁcant at p 6 0.05.
Figure 1 Male patient aged 54 years old, hypertensive, heavy smoker and dyslipidemic, presented with anterior STEMI of 1 h duration.
Patient was then transferred to cath. Lab for 1ry PCI with door-to-balloon time 40 min.
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92% in non-1ry PCI group), while 3.1% in 1ry PCI group and
5.6% in non-1ry PCI group presented with Killip class IV (car-
diogenic shock). Eight patients in 1ry PCI group and ﬁve pa-
tients in non-1ry PCI group were arrested at admission.
Four patients in each group required intubation and mechan-
ical ventilation.
Saman Rasoul et al.9 studied primary percutaneous coro-
nary intervention for STEMI: From clinical trial to clinicalpractice. This study reported that from 1994 through 2004, a
total of 4732 patients with STEMI were admitted for primary
PCI at the Isala Clinics (Zwolle, Netherlands). Mean age of the
patients was 61 (19–95) years, 76% were male, 11% had a his-
tory of previous myocardial infarction, 11% had diabetes mel-
litus, 31.9% were hypertensive, 48.5% were current smokers
and 44.3% were dyslipidemic.
Juwana et al.11 studied primary coronary intervention for
STEMI in Indonesia and the Netherlands. This study reported
170 M. Sadaka et al.that a total of 596 patients were treated by primary PCI, 568 in
Zwolle and 28 in Jakarta. Patients in Indonesia were younger
(54 vs. 63 years), more often had diabetes (36 vs. 12%), high
lipids (46 vs. 19%) and were more often smokers (68 vs. 31%).
Fahim et al.10 studied Outcomes of Primary Percutaneous
Coronary Intervention at a Joint Commission International
Accredited Hospital in a Developing at the Aga Khan Univer-
sity Hospital (AKUH) in Karachi, Pakistan. A total of 277 sub-
jects were included in this study. The mean age of the patients
was 54.9 ± 11.2 years, 76.5% were male, 32.1% had diabetes,
46.9% were hypertensive, 32.9% were current smokers, 45.8%
were dyslipidemic, 12.3% had a prior MI, 6.9% had history of
prior PCI and 1.4% had history of cerebrovascular stroke.
Andrew et al.12 studied rescue PCI in MERLIN trial. This
trial reported that 307 patients with failed thrombolysis to
rescue PCI or conservative care reﬂects the practice of PCI per-
formed in the United Kingdom, 153 patients undergo rescue
PCI, mean age 63.0, 71% of them were male, 11.8% had his-
tory 0f DM, 40.5% had history of HTN, 19.0% had history
of dyslipidemia, 41.8% were current smoker and 11.1% had
history of previous MI.
We found in our study that the mean age is 55 years which
is lower than the mean age in other studies published in the lit-
erature in the developed countries, but more or less equal to
that in studies published in third-world nations because of
the pandemic of diabetes in our country which may in part
be associated with the metabolic syndrome and stressing the
urgent need for a national policy for primary and secondary
prevention of diabetes and dyslipidemia. The prevalence of
smoking in our country is still high inspire of aggressive public
health efforts to limit tobacco use.
4.2. Admission timing characteristics
4.2.1. Primary PCI group
The median time from onset of symptoms to presentation was
240 min and the median door-to-balloon time was 60 min in
primary PCI group (288 patients).
Saman Rasoul et al.9 reported that from 1994 to 2004, pa-
tient delay remained unchanged (3.8 ± 4.3 h), while door to
balloon time decreased signiﬁcantly from (1.0 ± 0.9 h) to
(0.9 ± 0.2 h).
Juwana et al.11 reported that time between symptom onset
and hospital admission was longer in Indonesian patients
(413 ± 325 vs. 214 ± 202 min) and Time from hospital admis-
sion to balloon inﬂation was much longer in Indonesia than in
Netherlands (189 ± 127 vs. 49 ± 33 min).
Sune Pedersen et al.13 reported that the median door-to-bal-
loon time was 97 min (interquartile range [IQR], 65–135) and
the total symptom-to-balloon time was 214 min (IQR, 145–310).
Busk et al.14 studied the DANAMI-2 trial reported that the
median door-to-balloon time was 109 min and the total symp-
tom-to-balloon time was 216 min.
Abdessalem et al.15 reported that the average time of angi-
oplasty compared with the onset of pain was 10.9 ± 6.8 h in
the total population (<24 h) and 6.6 ± 2.6 h in the subgroup
of 139 patients taken before 12 pm. Only 32.2% of patients
had angioplasty in the ﬁrst 6 h.
Fahim et al.10 reported that the median time from onset of
symptoms to presentation was 160 min, and the median door-
to-balloon time was 90 min.Petr Widimsky et al.16 studied the reperfusion therapy for
STEMI in Europe, description of the current situation in 30
countries, reported that the time from symptom onset to the
ﬁrst medical contact (FMC) ranged from 60 to 210 min and
FMC-balloon time was between 60 and 177 min.
In our study there was time delay between patient’s symp-
toms and ﬁrst medical contact ranged from 30 to 720 min
which is considered higher than that published in the literature
in many developed countries insisting that our patients have to
be better educated to minimize this delay through media and
public awareness. The mean door-to-balloon time was a
68.91 ± 23.25 min which is more or less similar to that in
many developed countries.16 It has been suggested that once
door-to-balloon times exceed 90 min, the beneﬁts begin to de-
cline and mortality increased.
4.2.2. Non-primary PCI group
4.2.2.1. Rescue PCI group (95 patients). In our study; the time
from onset of pain-to-thrombolytic was 274.35 ± 277.78 min,
while the median time between end of failed thrombolytic ther-
apy and the rescue PCI was 420 min.
Andrew et al.12 reported that, the time from onset of pain-
to-thrombolytic was 327 ± 121 min and time between throm-
bolytic to rescue PCI was 146 min.
Gershlick et al.17 studied Rescue Angioplasty versus Con-
servative Therapy of Repeat Thrombolysis (REACT) trial.
This trial reported that 427 patients with failed thrombolysis
as deﬁned by lack of >50% resolution of ST segment changes
at 90 min. One hundred and forty-four patients undergo rescue
PCI. Pain-to-thrombolytic was 140 min and time between
thrombolytic to rescue PCI was 274 min.
David et al.18 studied Rescue Percutaneous Coronary Inter-
vention for Failed Thrombolysis study. In the study group
consisted of 214 consecutive patients had failed thrombolysis,
178 patients (83%) undergo rescue PCI. Symptom onset to
thrombolytic therapy was 5.6 h and the mean time from
thrombolytic therapy to PCI was 7.0 h.
4.2.2.2. Post successful thrombolytic (35 patients). In our
study; the time from onset of pain-to-thrombolytic was
85.05 ± 90.13 min, the median time between end of successful
thrombolytic therapy and PCI was 810 min.
Bruno et al.19 studied the beneﬁcial effects of immediate
stenting after thrombolysis in acute myocardial infarction
in (SIAM III) trial. This trial reported that 163 STEMI pa-
tients treated with reteplase within 12 h of symptoms, 82 pa-
tients randomized to immediate stenting of the IRA (mean
time 3.5 h) and 81 patients elective stenting of the IRA after
2 weeks or earlier in case of ongoing ischemia. The time
from thrombolysis to angiography was 3.5 ± 2.3 h in imme-
diate stenting group versus 11.7 ± 6.8 days in delayed stent-
ing group.
Ellen et al.20 studied efﬁcacy and safety of immediate angi-
oplasty versus ischemia-guided management after thromboly-
sis in acute myocardial infarction in NORDISTEMI study.
This trial reported that 266 patients with acute STEMI living
in rural areas with more than 90-min transfer delays to PCI
were treated with tenecteplase, 134 patients transferred to early
invasive group and 132 patient ischemia guided PCI. There
were no relevant differences in baseline data between the two
study groups. The time from thrombolysis to angiography
A guideline based approach of percutaneous coronary intervention in acute myocardial infarction 171was 120–158 min in early invasive group versus 5.5 days in
conservative group.
4.2.2.3. PCI in late presentation (32 patients). In our study
only 32 patients underwent late PCIP 24 h and 648 h with-
out thrombolytic therapy; time from onset of pain-to-emer-
gency department was 1451.11 ± 1458.23 min, while chest
pain to late PCI median time was 2160 min.
Philippe et al.21 studied DEsobstruction COronaire en
Post-Infarctus (DECOPI). Two hundred and twelve patients
with a ﬁrst Q-wave MI, 109 patients were randomized to per-
cutaneous revascularization, carried out 2–15 days after symp-
tom onset and 103 patients were randomized medical therapy.
Mehilli et al.22 studied role of PCI in patients with acute
STEMI presenting 12–48 h (median 23 h) after symptom on-
set, the patients, who were no longer symptomatic, in
BRAVE-2 (Bavarian Reperfusion Alternatives Evaluation)
trial. This study carried out on 365 patients, 182 patients of
them were randomly assigned to an invasive strategy, which
consisted of PCI with stenting, versus 183 patients assigned
to conservative therapy.
4.3. Baseline characteristics of coronary angiography
As regards angiographic data, LAD represented the culprit
vessel in 60.9% of our patients and initial TIMI ﬂow was less
than 2 in 78.5% of patients in 1ry PCI group and 48.8% in
non-1ry PCI group.
Juwana et al.11 reported that LAD represented the culprit
lesion in 39% of patients in Netherlands and 46% of patients
in Indonesia and RCA was the culprit lesion in 39% of pa-
tients in both countries. Fifty-one percentage of patients had
multivessel disease in Netherlands vs. 75% in Indonesia. TIMI
ﬂow prior to angioplasty was 0 in 59% of patients in Nether-
lands vs. 68% in Indonesia.
Sune Pedersen et al.13 reported that 55% of patients had
single vessel disease, 21% of patients had 2 vessels disease
and 15% of patients had 3 vessels disease. LAD represented
the culprit lesion in 37% of patients, RCA was the culprit le-
sion in 36% and LCX was the culprit lesion in 8% of patients.
Abdessalem et al.15 reported that initial TIMI ﬂow was less
than 2 in 92.3% of patients and the LAD artery was the culprit
in 58.6% of cases.
Fahim et al.10 reported that multivessel disease was in
56.3% of patients, LAD represented the culprit lesion in
53.8% of patients, RCA was the culprit lesion in 34.3% and
LCX in 11.9%. Baseline ﬂow was TIMI 0 or 1 in 97.4% of pa-
tients and TIMI 2 or 3 in 2.6% of patients.
LAD was the culprit lesion in majority of cases in that we
were similar to all the comparing studies above followed by
RCA and lastly LCX.
4.4. Procedural-related techniques and materials
Glycoprotein (GP) IIb/IIIa inhibitor was used in 97.6% of pa-
tients in primary PCI group while not utilized in non-primary
PCI group. Thrombus aspiration was done in 41% of patients
in primary PCI group and 12.3% in non-primary PCI group.
During the angioplasty procedure, direct stenting was 41.3%
among 1ry PCI patients and 56.2% among non-primary PCI
patients. Bare metal stents (BMS) were used in 71.3% of wholepatients while drug eluting stents (DES) were used in 28.5% of
whole patients. Multivessel PCI at the same setting was done
in 8.2% of the whole patients.
Sune Pedersen et al.13 reported that GP IIb/IIIa inhibitor
was used at the discretion of the operators in 28% of patients.
POBA was applied to 6% of patients only. BMS were used in
40% of patients while DES were used in 37% of patients.
Abdessalem et al.15 reported that GP IIb/IIIa inhibitor was
used in 12% of patients. Stenting was performed in 96.2% with
an average of 1.2 stents per patient was 2.9 ± 2.3 mm in diam-
eter and 24.6 ± 13.3 mm in length. Direct stenting was 48.2%
among patients and the predilatation balloon or thrombo-
aspiration prior to stenting in 44.2% and 3.8% of cases
respectively.
Fahim et al.10 reported that GP IIb/IIIa inhibitor was used
at the discretion of the operators in 90% of patients. Stents
were used in 96% of patient while POBA was applied to 4%
of patients only. Multivessel PCI at the same setting was ap-
plied to 4.3% of patients only.
David et al.18 stated that, thrombus aspiration was done in
21%. Stents were used in (88%). GP IIb/IIIa inhibitor was
administered in (92%), IABP was placed in (17%).
4.5. In-hospital, 30 days and 6-months outcomes
In-hospital, 30 days and 6-months mortality were respectively
2.1%, 0.7% and 1.1% in primary PCI group while 2.5%, 3.2%
and 2.6% in non-primary PCI group. In-hospital, 30 days and
6-months re-infarction occurred in 0.3%, 1.1% and 0.7% of
patients in primary PCI group while 0.0%, 1.3% and 0.7%
in non-primary PCI group respectively. In-hospital, 30 days
and 6-months TVR occurred in 0.7%, 0.7% and 1.1% of pa-
tients in primary PCI group while 0.0%, 1.3% and 0.7% in
non-primary PCI group respectively. There was no emergent
coronary artery bypass graft (CABG).
Abdessalem et al.15 reported that the cumulative mortalities
were 5.3% in-hospital and the respective cumulative major ad-
verse cardiac events were 7.7% in-hospital. The hemorrhagic
events were observed in 1.4% of patients.
Fahim et al.10 reported that twenty-three patients died in
the hospital (8.3%), 5 patients (1.8%) developed stroke, 9 pa-
tients needed in-hospital CABG and major bleeding occurred
in 4.3% of patients.
Petr Widimsky et al.16 studied the reperfusion therapy for
STEMI in Europe, description of the current situation in 30
countries, reported that the in-hospital mortality of all consec-
utive STEMI patients treated by primary PCI were between
2.7 and 8%.
In rescue PCI, David et al.18 reported that hospital MACE
was 10.7% as death occurred in 3.4%, re-infarction in 7.3%,
TVR in (3.4%). Four patients 2.2% developed major bleeding
and 5.1% developed minor bleeding.
Regarding MACE in early routine PCI, Bruno et al.19
found that 30-days MACE in immediate stenting group
7.3% (death in 4.9%, re-infarction 2.4%, TVR 2.4%) versus
13.4% in delayed stenting group (death 9.9%, re-infarction
2.5%, TVR 2.5%), while found that overall MACE during
6 months was 24.4 in immediate stenting (death 4.9%, re-
infarction 2.4% and TVR 19.5%) versus 34.6% in delayed
stenting group (death in 11.1%, re-infarction 2.5%, TVR
23.5%).
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30 days MACE occurred in eight patients in the invasive group
(4.4%) and 12 patients in the conservative group (6.6%)
Although this difference was not signiﬁcant (P= 0.37), the
study was underpowered to detect such a modest difference
in clinical outcomes.
Gabriel Steg et al.23 studied the Impact of Collateral Flow
to the Occluded Infarct-Related Artery on Clinical Outcomes
in Patients with Recent Myocardial Infarction, long-term out-
comes in 2173 patients with total occlusion of the infarct artery
3–28 days after myocardial infarction, a Report from the
Randomized Occluded Artery Trial. They concluded that late
recanalization of the infarct artery in addition to medical ther-
apy shows no beneﬁt compared to medical therapy alone.
5. Conclusion
 This is the ﬁrst report from ICC at Alexandria to provide a
comprehensive review of patient characteristics and out-
comes of a guideline based approach of PCI for STEMI.
 We reported a high initial success rate, excellent short and
intermediate-term outcomes, our results compared favor-
ably to western data despite many differences in facilities
and patient characteristics.
 As we believe in the importance of primary PCI as the
mainstay in treatment of STEMI; Egypt is currently con-
tributing to the European project of stent for life (SFL) as
a one of 10 target countries in the next few years.
6. Study limitations
Our study is not without limitations. First, the sample size is
relatively small compared to large studies published in the lit-
erature, and larger studies are needed to validate these results.
Second, there is a proportion of the delay-to-PCI comprises
the time taken by patients to decide whether they can proceed
with the procedure, based on ﬁnancial constraints. Third, our
data represent a single-center experience where the operators
are experienced and the hospital has good medical and para-
medical team and good ambulance system. Whether these re-
sults can be generalized to other hospitals in our country is
unclear. Finally, our use of historical data to compare our
experience with Western outcomes carries obvious limitations
and is by no means deﬁnitive. There are many differences both
in patient characteristics (age in our study was lower than in
the other studies; on the other hand, time from symptoms to
ﬁrst medical contact was higher) and selection methods.
Nevertheless, we feel that our data do enable us to make the
point that outcomes similar to the West may be possible in
developing countries, and further study, perhaps with a real-
time Western comparator group, would be in order.References
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